98%
921
2 minutes
20
Purpose: To compare the Clareon IOL with the Tecnis PCB00 IOL in terms of visual performance, refractive outcomes, glistenings occurrence, and quality-of-life outcomes.
Setting: Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Design: Single-center, single-masked, prospective, randomized controlled trial.
Methods: One hundred thirty-nine patients with bilateral cataracts were randomized to receive the Clareon (C IOL) or Tecnis (T IOL) IOL. Visual acuity, refraction, central corneal thickness (CCT), endothelial cell loss, contrast sensitivity, mesopic gap acuity, evaluation of glistenings, and rates of perioperative and postoperative complications were recorded. Quality-of-life outcomes were measured with the EuroQOL-5 dimensions questionnaire and the patient-reported outcome measures (PROMs) questionnaire. Optimized A-constants were available for the T IOL but not for the C IOL.
Results: Seventy-one patients (140 eyes) received the C IOLs and 68 patients (134 eyes) received the T IOLs. Data were analyzed for the first implanted eye. At 12 months, mean uncorrected distance visual acuity (logarithm of the minimum angle of resolution) was 0.02 ± 0.10 and 0.01 ± 0.08 (mean ± SD; P = .49; 95% CI, -0.02 to 0.04) in the C IOL and T IOL groups, respectively. Corrected distance visual acuity was -0.02 ± 0.09 and -0.03 ± 0.06, respectively (P = .45; 95% CI, -0.02 to 0.04). The increase in CCT was 14 ± 19 and 16 ± 28 μm, respectively (P = .63; 95% CI, -10.16 to 6.16). Mean absolute refraction spherical equivalent error from target refraction was 0.41 ± 0.28 for the C IOL and 0.25 ± 0.2 for the T IOL groups (P = .002; 95% CI, 0.08 to 0.24). Glistenings were minimal (median grade 0), with no difference in grades between groups (P = .2). PROMs improved postoperatively and were similar in both groups.
Conclusions: There were no differences in visual outcomes between the Clareon IOL and Tecnis PCB00 IOL. Glistenings were rarely observed in either IOL with no difference in grades. There was no difference in perioperative or postoperative complications. Surgeon optimization of the A-constant for the Clareon IOL is recommended.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/j.jcrs.0000000000000201 | DOI Listing |
Am J Ophthalmol
September 2025
Dean McGee Eye Institute, University of Oklahoma, Oklahoma City, Oklahoma, USA. Electronic address:
Purpose: To compare refractive prediction accuracy using simulated keratometry (SimK) measurements obtained from a Scheimpflug tomographer (Pentacam AXL, Oculus) versus keratometry (K) measurements obtained from an optical biometer utilizing telecentric keratometry (IOLMaster 700 (IOLM700), Carl Zeiss Meditec AG) applied to modern IOL power calculation formulas.
Design: Retrospective accuracy and validity analysis METHODS: Setting: Private practice center STUDY POPULATION: Five hundred eighty-nine eyes with preoperative SimK and K measurements undergoing phacoemulsification and implantation of monofocal IOL (Clareon SY60WF IOL, Alcon Laboratories, Inc.).
Clin Ophthalmol
August 2025
Alcon Research, Fort Worth, TX, USA.
Purpose: To assess the real-world distance and intermediate visual outcomes, rotational stability, and adverse events (AEs) of patients implanted with a Clareon aspheric monofocal toric intraocular lens (IOL) preloaded in the AutonoMe delivery system (Alcon, USA; models CNA0T2 to CNA0T6) up to one-month postoperative.
Methods: Surgical charts from January 2021 to October 2023 were reviewed for adult patients (≥18 years) who previously received a CNA0T2 to CNA0T6 (T2 to T6) IOL during uneventful cataract surgery and were targeted for emmetropia/first minus. Overall, charts from 193 eyes of 121 patients were screened, with 161 eyes of 107 patients included in the study.
Clin Ophthalmol
August 2025
Otani Eye Clinic, Iwade, Wakayama, Japan.
Purpose: This study prospectively assessed the refractive and astigmatism prediction accuracy of intraoperative aberrometry, Optiwave Refractive Analysis (ORA), in eyes implanted with Clareon toric intraocular lenses (IOLs).
Patients And Methods: Patients with age-related cataracts who underwent phacoemulsification and toric IOL implantation using ORA were prospectively included in this single-center study. The absolute refractive prediction error (RPE) and rate of RPE for ORA, Sanders-Retzlaff-Kraft/Theoretical (SRK/T), and Barrett Universal II were evaluated 3 months after surgery.
Clin Ophthalmol
August 2025
NVISION Eye Centers, Rowland Heights, CA, USA.
Purpose: To evaluate cataract surgery outcomes following mix-and-match implantation of a trifocal and extended-depth-of-focus (EDOF) intraocular lens (IOL).
Setting: Single center, private practice.
Design: Single arm, non-interventional, ambispective study.
J Refract Surg
August 2025
International Vision Correction Research Centre, Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany.
Purpose: To evaluate the efficacy of refractive lens exchange (RLE) with a trifocal intraocular lens (IOL) implantation by assessing reading performance and visual acuity at near and intermediate distances.
Methods: This was a prospective interventional case series of 27 patients (54 eyes) at a university hospital who underwent a femtosecond laser-assisted RLE with Clareon PanOptix IOL (Alcon Laboratories, Inc) implantation. Visual acuity was tested before surgery and 6 months postoperatively and reading performance was evaluated using the Salzburg Reading Desk (SRD Vision) at near and intermediate distances.